Mettler-Toledo International Inc. (NYSE:MTD) Shares Purchased by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. grew its stake in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 18.0% in the 4th quarter, HoldingsChannel reports. The firm owned 34,370 shares of the medical instruments supplier’s stock after acquiring an additional 5,234 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in Mettler-Toledo International were worth $42,058,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of MTD. JPMorgan Chase & Co. raised its stake in Mettler-Toledo International by 14.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier’s stock valued at $332,634,000 after purchasing an additional 28,478 shares during the period. Quest Partners LLC raised its position in Mettler-Toledo International by 878.1% during the third quarter. Quest Partners LLC now owns 1,027 shares of the medical instruments supplier’s stock valued at $1,540,000 after buying an additional 922 shares during the period. Allspring Global Investments Holdings LLC boosted its holdings in shares of Mettler-Toledo International by 14.0% during the third quarter. Allspring Global Investments Holdings LLC now owns 1,240 shares of the medical instruments supplier’s stock worth $1,860,000 after purchasing an additional 152 shares during the period. M&T Bank Corp raised its stake in shares of Mettler-Toledo International by 14.3% during the 3rd quarter. M&T Bank Corp now owns 4,926 shares of the medical instruments supplier’s stock worth $7,387,000 after purchasing an additional 615 shares in the last quarter. Finally, Nordea Investment Management AB raised its holdings in Mettler-Toledo International by 29.8% during the fourth quarter. Nordea Investment Management AB now owns 105,823 shares of the medical instruments supplier’s stock valued at $129,919,000 after buying an additional 24,285 shares in the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

Insider Activity

In related news, Director Elisha W. Finney sold 76 shares of Mettler-Toledo International stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total value of $99,693.00. Following the sale, the director now owns 240 shares of the company’s stock, valued at approximately $314,820. The trade was a 24.05 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Gerry Keller sold 140 shares of the stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total value of $175,572.60. Following the transaction, the insider now directly owns 6 shares of the company’s stock, valued at $7,524.54. This trade represents a 95.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.94% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on MTD shares. Robert W. Baird reduced their price target on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a report on Monday, November 11th. Stifel Nicolaus lowered their price target on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research report on Monday, November 11th. Wells Fargo & Company cut their price objective on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a report on Monday, November 11th. Citigroup raised Mettler-Toledo International from a “sell” rating to a “neutral” rating and raised their price target for the company from $1,200.00 to $1,300.00 in a report on Wednesday, December 11th. Finally, Wolfe Research initiated coverage on Mettler-Toledo International in a research note on Friday, December 13th. They issued a “peer perform” rating on the stock. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $1,351.25.

Mettler-Toledo International Stock Performance

MTD opened at $1,338.58 on Thursday. The company has a fifty day moving average price of $1,257.26 and a two-hundred day moving average price of $1,343.51. The firm has a market capitalization of $28.24 billion, a PE ratio of 36.09, a P/E/G ratio of 4.19 and a beta of 1.12. Mettler-Toledo International Inc. has a 52 week low of $1,133.46 and a 52 week high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $10.21 EPS for the quarter, beating analysts’ consensus estimates of $10.00 by $0.21. The business had revenue of $954.54 million during the quarter, compared to the consensus estimate of $941.93 million. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. Equities analysts forecast that Mettler-Toledo International Inc. will post 40.42 EPS for the current year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.